Synthesis of 1,3,4-Oxadiazoles as Selective T-Type Calcium Channel Inhibitors

Neuropathic pain, epilepsy, insomnia, and tremor disorder may arrive from an increase of intracellular Ca concentration through a dysfunction of T-type Ca channels. Thus, T-type calcium channels could be a target in drug discovery for the treatments of neuropathic pain and epilepsy. From rational drug design approach, a group of 2,5-disubstituted 1,3,4-oxadiazole molecules was synthesized and their selective T-type channel inhibitions were evaluated. The synthetic strategy consists of a short sequence of three reactions: (i) condensation of thiosemicarbazide with acid chlorides; (ii) ring closing by 1,3-dibromo-5,5- dimethylhydantoin; and (iii) coupling with various acid chlorides. 5-Chloro--(5- phenyl-1,3,4-oxadiazol-2-yl)thiophene-2-carboxamide () was found to selectively inhibit T-type Ca channel over Na and K channels in mouse dorsal root ganglion neurons and/or human embryonic kidney (HEK)-293 cells and to suppress seizure-induced death in mouse model. Consequently, compound is a useful probe for investigation of physiologic and pathophysiologic roles of the T-channel, and provides a basis to develop a novel therapeutic to treat chronic neuropathic and inflammatory pains.